Family history of breast cancer as a risk factor for ovarian cancer in a prospective study

Cancer

Volumn 107, Issue 5, 2006, Pages 1075-1083

  Kazerouni, Neely ^a   Greene, Mark H ^a   Lacey Jr , James V ^a   Mink, Pamela J ^b   Schairer, Catherine ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EXPONENT INC   (United States)

Author keywords

Breast cancer; Family history; Ovarian cancer

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETIC RISK; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MENOPAUSE; ONCOGENE; OVARY CANCER; PARITY; POISSON DISTRIBUTION; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RELATIVE; TELEPHONE; UNITED STATES;

AGE FACTORS; AGED; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33747876642     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22082     Document Type: Article

References (27)

1. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut. 1935-1982. Natl Cancer Inst Monogr. 1985;68:99-112.
2. Wooster R, Weber BL. Breast and ovarian cancer. N Engl J Med. 2003;348:2339-2347.
3. Schildkraut JM, Thompson WD. Relationship of epithelial ovarian cancer to other malignancies within families. Genet Epidemiol. 1988;5:355-367.
4. Kerber RA, Slattery ML. The impact of family history on ovarian cancer risk. The Utah Population Database. Arch Intern Med. 1995;155:905-912.
5. Parazzini F, Negri E, La Vecchia C, Restelli C, Franceschi S. Family history of reproductive cancers and ovarian cancer risk: an Italian case-control study. Am J Epidemiol. 1992;135:35-40.
6. Poole CA, Byers T, Calle EE, Bondy J, Fain P, Rodriguez C. Influence of a family history of cancer within and across multiple sites on patterns of cancer mortality risk for women. Am J Epidemiol 1999;149:454-462.
7. Tung KH, Goodman MT, Wu AH, et al. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives. Am J Epidemiol. 2004;159:750-758.
8. Cramer DW, Hutchison GB, Welch WR, Scully RE, Ryan KJ. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst. 1983;71:711-716.
9. Schildkraut JM, Risch N, Thompson WD. Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am J Hum Genet. 1989;45:521-529.
10. Peto J, Easton DF, Matthews FE, Ford D, Swerdlow AJ. Cancer mortality in relatives of women with breast cancer: the OPCS Study. Office of Population Censuses and Surveys. Int J Cancer. 1996;65:275-283.
11. Ziogas A, Gildea M, Cohen P, et al. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:103-111.
12. Nelson CL, Sellers TA, Rich SS, Potter JD, McGovern PG, Kushi LH. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Genet Epidemiol. 1993;10:235-244.
13. Vachon CM, Mink PJ, Janney CA, et al. Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women. Epidemiology. 2002;13:66-71.
14. Eccles DM. Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics. Ann Oncol. 2004;15(Suppl 4):P133-138.
15. Murff HJ, Spiegel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004;292:1480-1489.
16. Nelson HD, Huffman LH, Fu R, Harris EL. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the US Preventive Services Task Force. Ann Int Med. 2005;143:362-379.
17. World Health Organization. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: WHO, 1977.
18. Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure user's guide. HiroSoft International, Seattle, Washington, 2000.
19. Byrne C, Brinton LA, Haile RW, Schairer C. Heterogeneity of the effect of family history on breast cancer risk. Epidemiology. 1991;2:276-284.
20. Webb PM, Byrne C, Schnitt SJ, et al. Family history of breast cancer, age and benign breast disease. Int J Cancer. 2002;100:375-378.
21. NIH Consensus Development Panel on Ovarian Cancer. JAMA. 1995;273:491-497.
22. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005;143:355-361.
23. Murff HJ, Byrne D, Syngal S. Cancer risk assessment. Quality and impact of the family history interview. Am J Prev Med. 2004;27:239-245.
24. Sweet KM, Bradley TL, Westman JA. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol. 2002;20:528-537.
25. Anderson MR, Bowen D, Yasui Y, McTiernan A. Awareness and concern about ovarian cancer among women at risk because of a family history of breast or ovarian cancer. Am J Obstet Gynecol 2003;189:S42-S47.
26. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 1998;105:493-499.
27. Lichtenstein P, Holm NV Verasalo PK, et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark and Finland. N Engl J Med. 2000;343:78-85.